RT Journal Article
SR Electronic
T1 Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre
JF Journal of Clinical Pathology
JO J Clin Pathol
FD BMJ Publishing Group Ltd and Association of Clinical Pathologists
SP jclinpath-2022-208203
DO 10.1136/jclinpath-2022-208203
A1 Russo, Gianluca
A1 Pepe, Francesco
A1 Pisapia, Pasquale
A1 Palumbo, Lucia
A1 Nacchio, Mariantonia
A1 Vigliar, Elena
A1 Pallante, Pierlorenzo
A1 Parente, Paola
A1 Fassan, Matteo
A1 Graziano, Paolo
A1 Bellevicine, Claudio
A1 Troncone, Giancarlo
A1 Malapelle, Umberto
A1 Iaccarino, Antonino
YR 2022
UL http://jcp.bmj.com/content/early/2022/05/11/jclinpath-2022-208203.abstract
AB DNA mismatch repair complex is involved in the maintenance of DNA stability. In the recent years, a plethora of technical approaches for microsatellite instability (MSI) analysis emerged. Here, we review the results of our MSI status evaluation by adopting a customised workflow on microfluidic system obtained in 4 years of diagnostic routine practice. Data from MSI status were retrieved from our institutional archive covering the period from January 2017 to December 2021. Microfluidic analysis was carried out on microfluidic platform. Results were inspected with a proprietary software. Overall, microsatellite stability (MSS) and MSI-high (MSI-H) profile was detected in n=423/458 (92.36%) and n=35/458 (7.64%) patients with metastatic CRC (mCRC), respectively. In addition, n=78/86 (90.70%) and n=8/86 (9.30%) patients without CRC showed an MSS and MSI-H profile. This review highlights the suitability of microfluidic approach in patients with cancer for MSI testing.